Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing-Reference-Cited by-同舟云学术

Germline BRCA mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing

Published:2017-08-07 Issue:1 Volume:36 Page:163-169
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Lee Kyoungmin,Yoo Changhoon,Kim Kyu-pyo,Park Kyoung-Jin,Chang Heung-Moon,Kim Tae Won,Lee Jae-Lyun,Lee Woochang,Lee Sang Soo,Park Do Hyun,Song Tae Jun,Seo Dong Wan,Lee Sung Koo,Kim Myung-Hwan,Shin Sang Hyun,Hwang Dae Wook,Song Ki Byung,Lee Jae Hoon,Kim Song Cheol,Ryoo Baek-Yeol

Funder

Asan Institute for Life Sciences, Asan Medical Center

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/article/10.1007/s10637-017-0497-1/fulltext.html

Reference28 articles.

1. Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9–29

2. Heestand GM, Murphy JD, Lowy AM (2015) Approach to patients with pancreatic cancer without detectable metastases. J Clin Oncol 33(16):1770–1778

3. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H et al (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350(12):1200–1210